Search company, investor...

Founded Year

1997

Stage

Acquired | Acquired

Total Raised

$51.6M

About MicroVention

MicroVention, founded in 1997, sells a catheter-based implant for the treatment of cerebral aneurysms as an alternative to an invasive craniotomy. MicroVention's HydroCoilO Embolic System and MicroPlexTM coil system are based on best of breed technology and have proved to be highly effective for the treatment of cerebral aneurysms. In addition, MicroVention recently launched its V-Trak detachment system, a device used to smoothly detach coils from the delivery device in the brain.

Headquarters Location

75 Columbia Suite A

Aliso Viejo, California, 92656,

United States

949-461-3314

Loading...

Loading...

MicroVention Patents

MicroVention has filed 303 patents.

The 3 most popular patent topics include:

  • vascular diseases
  • interventional radiology
  • implants (medicine)
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/5/2018

2/6/2024

Interventional radiology, Medical physics, Copolymers, Clusters of differentiation, Acoustics

Grant

Application Date

3/5/2018

Grant Date

2/6/2024

Title

Related Topics

Interventional radiology, Medical physics, Copolymers, Clusters of differentiation, Acoustics

Status

Grant

Latest MicroVention News

MicroVention Enters Transradial Access Therapy; Receives FDA Clearance of SOFIA™ EX 5F 115cm Intracranial Support Catheter

Sep 21, 2023

MicroVention Enters Transradial Access Therapy; Receives FDA Clearance of SOFIA™ EX 5F 115cm Intracranial Support Catheter September 21, 2023 at 09:46 am EDT Share MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced that the SOFIA™ EX 5F 115 cm Intracranial Support Catheter (Soft TOrqueable catheter For Intracranial Access) has received FDA 510(k) clearance on September 15, 2023, for transradial access in addition to transfemoral access. The unique design of the SOFIA™ EX 5F Catheter allows for great trackability and a large inside lumen provides a fast and effective way for tracking to intracranial locations in patients. Reinforced with a nitinol coil and stainless-steel braid, SOFIA™ EX offers support and kink resistance. The catheter has an inner PTFE liner throughout the entire length with 12 transition zones optimized for pushability. Transradial access utilizes the radial artery in the wrist as opposed to the femoral artery in the groin in transfemoral access. The SOFIA™ EX 5F radial access clearance proudly marks MicroVention’s first radial access product and signifies our commitment to innovation. MicroVention believes providers should have the ability to feel confident in our SOFIA™ EX 5F in either the transradial or transfemoral access approach. “We are pleased to receive FDA clearance for MicroVention’s SOFIA™ EX 5F Intracranial Support Catheter for transradial access,” said Carsten Schroeder, CEO, MicroVention. “This achievement signifies our commitment to radial neurointervention and represents our unwavering commitment to improving healthcare and helping to save patient lives, while striving to be at the forefront of innovation.” About MicroVention, Inc. Founded in 1997, MicroVention develops and markets medical devices that enable or significantly improve treatment of cerebrovascular diseases. In 2006, Terumo Corporation, a major worldwide medical device company headquartered in Tokyo, Japan, acquired MicroVention into their family of Companies. Terumo’s acquisition of MicroVention allowed both Companies to leverage their unique, proprietary technologies toward an increased focus on treating cerebrovascular diseases. Headquartered in California, MicroVention products are today sold in more than seventy countries through a direct sales organization alongside strategic distribution partnerships. Manufacturing facilities are in Aliso Viejo, California and San José, Costa Rica. For more information on MicroVention, please visit www.microvention.com. About Terumo Corporation Terumo (TSE:4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for one hundred years. Based in Tokyo and operating globally, Terumo employs more than 28,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large. For more information on Terumo, please visit www.terumo.com/about/profile. ** Editor’s Note: For a Clinical Glossary of Terms, please visit https://www.microvention.com/clinical-education/glossary. View source version on businesswire.com: https://www.businesswire.com/news/home/20230921168999/en/ Share

MicroVention Frequently Asked Questions (FAQ)

  • When was MicroVention founded?

    MicroVention was founded in 1997.

  • Where is MicroVention's headquarters?

    MicroVention's headquarters is located at 75 Columbia, Aliso Viejo.

  • What is MicroVention's latest funding round?

    MicroVention's latest funding round is Acquired.

  • How much did MicroVention raise?

    MicroVention raised a total of $51.6M.

  • Who are the investors of MicroVention?

    Investors of MicroVention include Terumo, Crosspoint Venture Partners, Advanced Technology Ventures, De Novo Ventures, Delphi Ventures and 7 more.

  • Who are MicroVention's competitors?

    Competitors of MicroVention include AcuFocus, Neoss, Endologix, Aptus Endosystems, Aeris Therapeutics and 7 more.

Loading...

Compare MicroVention to Competitors

V
Varix Medical

Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.

Spineology Logo
Spineology

Spineology provides anatomy-conserving spinal technologies for surgeons and their patients. Its surgical techniques conserve spinal bone, ligament, and muscle tissue, committed to increasing procedural efficiency, reducing surgical morbidity, and accelerating patient recovery. The company was founded in 1996 and is based in Saint Paul, Minnesota.

NeoChord Logo
NeoChord

NeoChord is a medical technology company engaged in the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, is a beating heart procedure, echo-guided treatment for patients with mitral valve regurgitation, and is proven to resolve and restore normal mitral valve function. It was formerly known as mValve. The company was founded in 2007 and is based in St. Louis Park, Minnesota.

M
MetaCure

MetaCure is a clinical-stage device company focused on the treatment of adult type II diabetes via an implantable pulse generator delivering electrical stimulation via gastric contractility modulation.

Endologix Logo
Endologix

Endologix is a company focused on the development and manufacturing of minimally invasive treatments for aortic disorders, operating within the medical devices industry. The company's main offerings include a variety of endovascular stent grafts, which are used for the treatment of abdominal aortic aneurysms (AAA), a condition characterized by a weakening of the wall of the aorta that can lead to a balloon-like enlargement. Endologix primarily serves the healthcare sector, particularly in areas related to vascular disease and aortic disorders. It was founded in 1992 and is based in Irvine, California.

Vertos Medical Logo
Vertos Medical

Vertos Medical operates as a medical device company. It focuses on developing minimally invasive treatments for lumbar spinal stenosis (LSS). Its technologies include Mild, which offers a guided therapeutic LSS treatment that requires no general anesthesia, no implants, and no stitches. The company was formerly known as X-Sten. It was founded in 2005 and is based in Aliso Viejo, California.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.